South African experts comment on FDA approval of dabigatran in atrial fibrillation.
Eric Q Klug
Cardiovascular journal of Africa
View on PubMed
United States Food and Drug Administration
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics
FDA Approves Dabigatran for Stroke Prevention in Atrial Fibrillation
Jack Ansell + 1 • Nov 06, 2017
Cost-Effectiveness of Dabigatran Exilate in Treatment of Atrial Fibrillation.
Giovanni Galvani + 6 • Sep 06, 2017
Atrial fibrillation in athletes
Vassil Traykov • Aug 27, 2017